The prevalence of infections hrp2/hrp3 deletions is very heterogenous even within a country leading to difficult decision making regarding when to adopt RDTs that detect lactate dehydrogenase (LDH), which until recently represent a drop in clinical sensitivity.14 This evidence concerns the gene HDGFL3 and infection.